A Trial to Investigate the Efficacy and Safety of NW Low-Glu ® in Patients With Type II Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: NW Low-Glu ®; Drug: Metformin Sponsors: Natural Wellness Egypt Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Egypt Health | Endocrinology | Fortamet | Metformin | Nutrition | Research